Search details
1.
Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial.
Arch Med Res
; 55(2): 102960, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38290199
2.
Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.
Trials
; 23(1): 148, 2022 Feb 14.
Article
in English
| MEDLINE | ID: mdl-35164840
Results
1 -
2
de 2
1
Next >
>>